Henan Taloph Pharmaceutical Stock Co.,Ltd reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 992.59 million compared to CNY 858.67 million a year ago. Revenue was CNY 993.91 million compared to CNY 863.68 million a year ago.

Net loss was CNY 38.33 million compared to CNY 25.43 million a year ago. Basic loss per share from continuing operations was CNY 0.0677 compared to CNY 0.0452 a year ago. Diluted loss per share from continuing operations was CNY 0.0677 compared to CNY 0.0452 a year ago.